Attached files

file filename
EX-99.3 - CURE BASED DEVELOPMENT, LLC MEDIA POWER POINT PRESENTATION - cbdMD, Inc.levelb_ex993.htm
EX-99.2 - CURE BASED DEVELOPMENT, LLC MARKETING POWER POINT PRESENTATION - cbdMD, Inc.levelb_ex992.htm
EX-99.1 - PRESS RELEASE DATED DECEMBER 20, 2018 - cbdMD, Inc.levb_ex991.htm
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported) December 21, 2018

LEVEL BRANDS, INC.
(Exact name of registrant as specified in its charter)
 
North Carolina
001-38299
47-3414576
(State or other jurisdiction of incorporation or organization)
(Commission File Number)
(I.R.S. Employer Identification No.)
 
4521 Sharon Road, Suite 450, Charlotte, NC 28211
(Address of principal executive offices)(Zip Code)
 
Registrant's telephone number, including area code: (704) 445-5800
 
not applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
☐            
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐            
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐            
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐            
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company ☑
 
 
If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 

 
 
 
 
Item 7.01        Regulation FD Disclosure.
 
On December 21, 2018, Level Brands, Inc. issued a press release announcing the closing of the merger agreement with Cure Based Development, LLC. A copy of this press release is furnished as Exhibit 99.1 to this report.
 
On December 21, 2018, Level Brands, Inc. also released two Power Point presentations to provide its shareholders and other interested individuals information on the historic business and operations of Cure Based Development, LLC. A copy of this Power Point presentation is furnished as Exhibit 99.2 and 99.3 to this report. As described in our Current Report on Form 8-K also filed on December [20], 2018 disclosing the closing of the merger, the business and operations of Cure Based Development, LLC will be continued post-closing by our wholly-owned subsidiary cbdMD, LLC.
 
Pursuant to General Instruction B.2 of Form 8-K, the information in this Item 7.01 of Form 8-K, including Exhibits 99.1, 99.2 and 99.3, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise be subject to the liabilities of that section, nor is it incorporated by reference into any filing of Level Brands, Inc. under the Securities Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
 
Item 9.01        Financial Statement and Exhibits

(d)                   Exhibits.
 
 
Incorporated by Reference
Filed or
Furnished
Herewith
No.
Exhibit Description
Form
Date Filed
Number
Press release dated December 20, 2018
 
 
 
Furnished
Cure Based Development, LLC Marketing Power Point presentation
 
 
 
Furnished
Cure Based Development, LLC Media Power Point presentation
 
 
 
Furnished
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
LEVEL BRANDS, INC.
 
 
 
Date: December 21, 2018
By:
/s/ Mark Elliott
 
 
Chief Financial Officer and Chief Operating Officer